Rui Kuai Selected Research

Rui Kuai Research Topics

Disease

20	Neoplasms (Cancer) 05/2024 - 10/2010
4	Melanoma (Melanoma, Malignant) 09/2020 - 01/2018
3	Atherosclerotic Plaque (Atheroma) 10/2021 - 03/2016
3	Carcinoma (Carcinomatosis) 01/2018 - 01/2017
2	Atherosclerosis 10/2021 - 02/2018
2	Adrenocortical Carcinoma 01/2017 - 01/2016
1	Autoimmune Diseases (Autoimmune Disease) 05/2024
1	Communicable Diseases (Infectious Diseases) 05/2024
1	Neoplasm Metastasis (Metastasis) 05/2024
1	Bites and Stings (Sting) 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Hypertriglyceridemia 10/2021
1	Fatty Liver 10/2021
1	Disease Progression 01/2021
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2021
1	Triple Negative Breast Neoplasms 12/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Neuroblastoma 05/2018
1	Ischemia 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 08/2017
1	Inflammation (Inflammations) 03/2017
1	Starvation 01/2016
1	Glioma (Gliomas) 11/2011

Drug/Important Bio-Agent (IBA)

11	HDL LipoproteinsIBA 01/2023 - 01/2016
5	Liposomes (Liposome)IBA 01/2023 - 10/2010
5	Immune Checkpoint InhibitorsIBA 01/2023 - 12/2017
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 11/2011
5	Peptides (Polypeptides)IBA 01/2023 - 08/2017
5	CholesterolIBA 10/2021 - 11/2011
4	LipidsIBA 01/2023 - 01/2017
4	AntigensIBA 11/2018 - 12/2017
4	VaccinesIBA 11/2018 - 01/2017
3	Immunoglobulin G (IgG)IBA 09/2020 - 01/2018
3	Scavenger Receptors (Scavenger Receptor)IBA 12/2019 - 08/2017
3	Cell-Penetrating PeptidesIBA 08/2014 - 10/2010
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2023 - 02/2018
2	Liver X ReceptorsIBA 10/2021 - 02/2018
2	Apolipoproteins E (ApoE)IBA 10/2021 - 02/2018
2	withalongolide A 4,19,27-triacetateIBA 12/2019 - 01/2017
2	NanoconjugatesIBA 12/2019 - 05/2018
2	Cysteine (L-Cysteine)FDA Link 08/2014 - 10/2010
2	Ethylene Glycol (Monoethylene Glycol)IBA 12/2011 - 10/2010
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2024
1	Biocompatible Materials (Biomaterials)IBA 05/2024
1	Poly I-CIBA 05/2024
1	Mitochondrial DNA (mtDNA)IBA 01/2023
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	Clathrin Light ChainsIBA 01/2023
1	InterferonsIBA 01/2023
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 10/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2021
1	ApolipoproteinsIBA 10/2021
1	SterolsIBA 10/2021
1	Ro 31-8425IBA 01/2021
1	Combined VaccinesIBA 09/2020
1	Cancer VaccinesIBA 09/2020
1	Freund's AdjuvantIBA 09/2020
1	NanovaccinesIBA 09/2020
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 09/2020
1	WithanolidesIBA 12/2019
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 12/2019
1	antiglomerular basement membrane antibodyIBA 01/2019
1	Phospholipids (Phosphatides)FDA LinkGeneric 02/2018
1	Drug CarriersIBA 02/2018
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 02/2018
1	EpitopesIBA 01/2018
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2018
1	OvalbuminIBA 01/2018
1	Mitoxantrone (Novantrone)FDA LinkGeneric 12/2017
1	Lipoproteins (Lipoprotein)IBA 08/2017
1	rho-Associated KinasesIBA 03/2017
1	Phosphotransferases (Kinase)IBA 03/2017
1	LectinsIBA 03/2017
1	CytokinesIBA 03/2017
1	LDL Receptors (LDL Receptor)IBA 03/2017
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2017
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 08/2014
1	fluorexon (calcein)IBA 10/2010
1	Indicators and Reagents (Reagents)IBA 10/2010

Therapy/Procedure

10	Immunotherapy 05/2024 - 01/2017
5	Therapeutics 01/2023 - 11/2011
3	Drug Therapy (Chemotherapy) 01/2023 - 01/2018
1	Aftercare (After-Treatment) 05/2018
1	Photothermal Therapy 01/2018
1	Limb Salvage 01/2018